ADAPTIMMUNE THERAPEUTICS PLC's ticker is ADAP and the CUSIP is 00653A107. A total of 49 filers reported holding ADAPTIMMUNE THERAPEUTICS PLC in Q1 2016. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $410,000 | +1.2% | 50,000 | -50.0% | 0.11% | -53.3% |
| Q4 2016 | $405,000 | -80.9% | 100,000 | -66.7% | 0.24% | -35.8% |
| Q3 2016 | $2,116,000 | +29.8% | 300,000 | +50.0% | 0.38% | -43.1% |
| Q2 2016 | $1,630,000 | -19.8% | 200,000 | -20.0% | 0.66% | -11.0% |
| Q1 2016 | $2,033,000 | -52.3% | 250,000 | -29.2% | 0.74% | -46.8% |
| Q4 2015 | $4,259,000 | +374.3% | 353,161 | +370.9% | 1.40% | +296.9% |
| Q3 2015 | $898,000 | – | 75,000 | – | 0.35% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM ASSET MANAGEMENT LLC | 6,287,101 | $4,903,939 | 2.63% |
| Syncona Portfolio Ltd | 1,377,294 | $1,074,289 | 1.60% |
| MPM BioImpact LLC | 5,095,912 | $3,974,811 | 1.06% |
| NEA Management Company, LLC | 17,079,778 | $13,322,227 | 1.03% |
| TANG CAPITAL MANAGEMENT LLC | 5,166,954 | $4,030,224 | 0.57% |
| PFM Health Sciences, LP | 10,423,135 | $8,130,045 | 0.38% |
| Matrix Capital Management Company, LP | 38,974,185 | $30,399,864 | 0.36% |
| Long Focus Capital Management, LLC | 10,963,158 | $8,551,263 | 0.31% |
| Acuitas Investments, LLC | 479,764 | $374,216 | 0.22% |
| Endurant Capital Management LP | 311,944 | $243,316 | 0.22% |